Impact of COVID-19 on Patients Hospitalized With Deep Vein Thrombosis and/or Pulmonary Embolism: A Nationwide Analysis
Related Experiment Video
Updated: Aug 17, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Adrija Hajra1, Akshay Goel2, Aaqib H Malik2
1Department of Internal Medicine, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY.
Insights
Coronavirus disease 2019 (COVID-19) patients with deep vein thrombosis (DVT) and pulmonary embolism (PE) had higher in-hospital mortality than flu patients. Risk factors for COVID-19-associated DVT/PE mortality include older age and certain chronic conditions.
Area of Science:
- Cardiology
- Infectious Diseases
- Pulmonology
Background:
- Coronavirus disease 2019 (COVID-19) is linked to an increased risk of venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Understanding the comparative in-hospital outcomes of patients with DVT/PE and concurrent COVID-19 versus flu is crucial for clinical management.
Purpose of the Study:
- To compare in-hospital outcomes for patients diagnosed with DVT and/or PE who have concurrent COVID-19 infection versus those with concurrent flu infection.
Main Methods:
- Analysis of the National Inpatient Sample (2019-2020) to identify adult hospitalizations with DVT and/or PE.
- Stratification of patients based on concomitant COVID-19 or flu infection.
- 1:1 propensity score matching to compare outcomes between the two groups.
Main Results:
- Higher incidence of cardiac arrest and inpatient mortality observed in the COVID-19 group compared to the flu group.
- Increased incidence of cardiogenic shock noted in the flu group.
- Independent predictors of mortality in COVID-19 patients with DVT/PE included advanced age, Hispanic ethnicity, diabetes, chronic kidney disease, arrhythmia, liver disease, coagulopathy, and rheumatologic diseases.
Conclusions:
- COVID-19 patients with DVT and/or PE face a higher risk of in-hospital mortality and cardiac arrest compared to flu patients.
- Specific demographic and comorbidity factors significantly predict mortality in COVID-19 patients with DVT/PE.
Abstract:
The Coronavirus disease 2019 (COVID-19) infection predisposes patients to develop deep vein thrombosis (DVT) and pulmonary embolism (PE). In this study, we compared the in-hospital outcomes of patients with DVT and/or PE with concurrent COVID-19 infection vs those with concurrent flu infection. The National Inpatient Sample from 2019 to 2020 was analyzed to identify all adult admissions diagnosed with DVT and PE. These patients were then stratified based on whether they had concomitant COVID-19 or flu. We identified 62,895 hospitalizations with the diagnosis of DVT and/or PE with concomitant COVID-19, and 8155 hospitalizations with DVT and/or PE with concomitant flu infection. After 1:1 propensity score match, the incidence of cardiac arrest and inpatient mortality were higher in the COVID-19 group. The incidence of cardiogenic shock was higher in the flu group. Increased age, Hispanic race, diabetes, chronic kidney disease, arrhythmia, liver disease, coagulopathy, and rheumatologic diseases were the independent predictors of mortality in patients with DVT and/or PE with concomitant COVID-19.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction

